34 results on '"Scagnolari, Carolina"'
Search Results
2. Interferon-ε as potential inhibitor of Chlamydia trachomatis infection
3. High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis
4. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
5. Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection
6. A single centre study of viral community-acquired pneumonia in children: No evidence of SARS-CoV-2 from October 2019 to March 2020
7. Chapter 11 - Interferons in human papillomavirus infection: antiviral effectors or immunopathogenic role?
8. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients
9. Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity
10. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
11. Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study
12. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response
13. Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses
14. Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use
15. TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections
16. Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses
17. List of contributors
18. Interferon lambda 1–3 expression in infants hospitalized for RSV or HRV associated bronchiolitis
19. The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
20. High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
21. High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic
22. Chapter 15 - MicroRNAs and the immune system
23. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
24. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
25. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients
26. Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years
27. List of contributors
28. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy
29. Probiotics and COVID-19
30. Sa1934 – The Fecal-Anti Candida Activity Can Be Modulated by Probiotic Administration
31. Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis
32. Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon
33. Expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
34. Treatment of SARS with human interferons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.